Eastern Capital LTD's Net Worth
$354 Million
Who is Eastern Capital LTD?
Eastern Capital LTD has an estimated net worth of $354 Million. This is based on reported shares across multiple companies, which include AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, CYTOKINETICS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., and TAPIMMUNE INC.
SEC CIK
Eastern Capital LTD's CIK is 0001408408
Past Insider Trading and Trends
2016 was Eastern Capital LTD's most active year for acquiring shares with 6 total transactions. Eastern Capital LTD's most active month to acquire stocks was the month of April. 2020 was Eastern Capital LTD's most active year for disposing of shares, totalling 9 transactions. Eastern Capital LTD's most active month to dispose stocks was the month of July. 2020 saw Eastern Capital LTD paying a total of $6,285,000.40 for 29,341,667 shares, this is the most they've acquired in one year. In 2020 Eastern Capital LTD cashed out on 29,592,160 shares for a total of $98,166,409.01, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AASTROM BIOSCIENCES INC (VCEL) Snapshot price: $45.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +85.30% | 362.5K |
$4.80 | $1,740,000.00 | 787.49K |
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PEREGRINE PHARMACEUTICALS INC (CDMO) Snapshot price: $9.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +64.53% | 850K |
$2.00 | $1,700,000.00 | 2.17M |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +105.98% | 4.44M |
$1.74 | -$74,160,683.17 | 8.63M |
Aug 7 - Aug 11
| |||
Form 4
| -11.42% | -4.27M |
$4.27 | -$18,220,725.85 | 33.11M |
Aug 4 - Aug 6
| |||
Form 4
| +35.16% | 2.2M |
$0.90 | $1,980,000.00 | 8.46M |
Jul 12
| |||
Form 4
| +36.80% | 1.68M |
$0.90 | $1,515,000.60 | 6.26M |
Jun 26
| |||
Form 4
| +35.56% | 12M |
$0.20 | $2,400,000.00 | 45.74M |
Nov 30
| |||
Form 4
| +23.86% | 6.5M |
$0.62 | $4,043,000.00 | 33.74M |
Apr 7
| |||
Form 4
| +24.06% | 5.28M |
$0.59 | $3,122,520.00 | 27.24M |
Jan 25
| |||
Form 4/A
| +51.87% | 7.5M |
$0.40 | $3,000,000.00 | 21.96M |
Oct 15
| |||
Form 4
| +44.60% | 4.46M |
—
|
—
| 14.46M |
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TAPIMMUNE INC (MRKR) Snapshot price: $3.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +11.47% | 416.67K |
$1.20 | $500,000.40 | 4.05M |
Feb 18
| |||
Form 4
| +32.50% | 1.3M |
$2.40 | $3,120,000.00 | 5.3M |
May 14
| |||
Form 4
| +40.00% | 8M |
$0.50 |
—
| 28M |
Aug 10
| |||
Form 4
| +100.00% | 10M |
$0.20 | $2,000,000.00 | 20M |
Sep 9
| |||
Form 4
| +100.00% | 5M |
$0.50 | $2,500,000.00 | 10M |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||